S 3974
117th Congress
Senate
Health
Disability and health-based discrimination
Drug therapy
Immunology and vaccination
Infectious and parasitic diseases
State and local government operations
Ending Discrimination in COVID–19 Treatments Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 31, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 31, 2022
Introduced in Senate
Plain-English summary
Ending Discrimination in COVID-19 Treatments Act
This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19.
As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1